|
Partnership |
Project |
| Guangdong Techpool Bio-Pharma |
Nycomed acquired 51.34% of the shares of Guangdong Techpool Bio-Pharma Co., Ltd., a fast-growing Chinese pharmaceutical company based in Guangdong.
See also press release |
With the acquisition of Techpool, Nycomed significantly expanded its presence in China. Techpool is a fast-growing Chinese bio-pharmaceutical company based in Guangdong. It was founded in 1993, and specialises in the research, development, manufacturing and marketing of biologic drugs derived from natural sources. |
| Laboratorios Farmacol S.A., Colombia |
Nycomed signed an agreement for the acquisition of Farmacol to further grow its presence in the Latin American region. |
Farmacol will provide Nycomed access to the high-growth (+14%) Colombian pharmaceutical market. |
| Sanofi-Aventis and Zentiva |
Nycomed agreed with Sanofi-Aventis and Zentiva to purchase 20 branded generic products in several Central and Eastern European countries.
See also press release |
Nycomed purchased a portfolio of branded generic products in the Czech Republic, Slovakia, Romania, Hungary, Estonia, and Bulgaria, with a total annual turnover of approximately € 17 million.
See also Nycomed worldwide |
| Bradley Pharmaceuticals |
Nycomed signed definitive agreement to acquire Bradley Pharmaceuticals, Inc., strengthening US specialty business.
See also press release |
The acquisition added further branded dermatologics to the PharmaDerm division of Nycomed US and has provided an enhanced platform for in-licensing and co-promotion of dermatology products.
Visit Nycomed US |
| Altana Pharma |
Nycomed purchased Altana Pharma from Altana in 2007.
See also press release |
The combined business led to an outstanding new healthcare company with increased market strength and greater access to new products. |